Jordan V. Wang

Outdated dermatologic drug samples and obligations to the patient

A 37-year-old man with a slightly raised, red, scaly patch on his left arm is seen in the clinic of an academic teaching hospital by a young dermatologist. Following examination and biopsy, he is found to have squamous cell carcinoma in situ. The patient was recently laid off fromwork and had lost access to his health insurance. He is struggling to make ends meet for his family, so it would be difficult for him to cover any extraneous health-related expenses. Upon relaying this information to the dermatologist, the patient is provided with a full course of 5-fluorouracil (topical cream 5%) from the clinic’s sample cabinet. Later in the day, it is discovered that the same batch of drugs has been outdated for more than 4 months. Because the dermatologist was only recently hired, she worries that she will be severely reprimanded for her failure to inspect the expiry date.

Counterfeit esthetic devices and patient safety in dermatology

This study addresses the dilemma concerned with meeting patients who may have encountered counterfeit esthetic devices in the marketplace. Over the past several years, we have witnessed a rise in counterfeit injectables and medical devices in our field. Often times, the procedures are marketed to patients at significantly reduced prices compared to competitors. Patients may be unaware that counterfeit devices exist and may unknowingly have procedures completed using untested and uncertified devices. It is important for clinicians to recognize when their patients may be encountering counterfeit devices, know what to do in this situation, and offer the best recommendations.

Resident experiences with social media: modernizing dermatology training

nantly lymphocytic, infiltrate in the dermis. Clinical and histological findings are quite different from those of our case; however, endothelial cells in the skin may not function properly because of long-term exposure to VEGFR inhibitor. Furthermore, intravascular occlusive fibrin thrombi were observed, and reparative perivascular fibrosis led to the development of CCV. It is possible that various stimulations, such as an anticancer drug and thrombi, caused microinjury and dysfunction of the small blood vessels of the skin and clinically represented telangiectasia.

Business administration training for dermatology residents: Preparing for the business of medicine

Previous studies have evidenced the lack of practice management and business training components in the residency curriculum, and that satisfaction with this training, when provided, was low. Whether considered good or bad, medicine has been moving increasingly toward becoming more business centric. Dermatology represents a unique field, because most residents choose to pursue private practice, where competent business skills are helpful to running a successful clinic. Our study examines the current state of business administration training for dermatology residents in Accreditation Council for Graduate Medical Education-approved programs as of 2017 to 2018. Our results show that residents both value and desire business administration training; however, the current training provided is considered to be insufficient and inadequate. Promoting and encouraging the teaching of business administration skills, while still balancing core competencies, may help to prepare residents in navigating the future of our field.

Language barriers to informed consent for dermatologic interventions

A n ethical dilemma may present itself when dermatologistsmust obtain informed consent from patients with limited English-language proficiency. With an increasingly diverse populationeboth culturally and linguisticallyeand the significant role that biopsies play in our field, it is crucial that dermatologists learn how to navigate this ethical quandary through recognizing the importance of using trained medical interpreters rather than untrained, biased, and/or minor individuals, eg, most